With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
PARTNER, RIFLE, TWENTE, transcatheter valves, novel DES, and renal denervation — Drs. Worthley and Meredith give their take on the hot topics for the interventionalist.
Stroke rates are higher with transcatheter aortic-valve implantation vs surgical valve replacement. Dr. Windecker discusses possible explanations and strategies to minimize stroke with surgeon Dr. Kappetein.
When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.
At risk for SCA after PCI? No problem — insert an ICD, right? Not so fast. The rationale behind why you may not get reimbursed. What are the alternatives?
Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.
Our expert panelists Drs. Leon and Di Mario discuss 2 complex cases presented by Drs. Byrne and Lee with challenging questions for the audience along the way. Take the challenge and see your peers' responses.
Dr. Hermiller reviews the ACC late-breaking PARTNER cohort A data; Dr. Leon summarizes the PARTNER program; Dr. Mack addresses risk scores; and Dr. Popma gives an update on the other major US trial.
At risk for SCA after PCI? No problem — insert an ICD, right? Not so fast. The rationale behind why you may not get reimbursed. What are the alternatives?
Drs. Rao, Steg, Jolly, and Mann review the results of the RIVAL trial and discuss how procedural and therapeutic strategies may improve patient outcomes.
A 77-year-old man presented with non-STEMI. Cardiac catheterization on August 30, 2011 revealed 3-vessel CAD (95% ostial RCA, 50% distal LM, 70% to 75% multiple lesions in LAD, and 70% OM2) and near-normal systolic LV function. Patient underwent PCI of culprit RCA vessel using XienceŽ V DES. The patient now has crescendo angina and the treatment plan is for FFR-guided PCI of LAD and/or LMCA.
An 86-year-old woman with prior DES PCI of mid-LAD presented with CCS class IV angina. Cardiac catheterization on October 21, 2011 revealed 3-vessel CAD and normal LV function and new culprit 90% lesion in distal LAD. Patient underwent PCI of distal LAD using XienceŽ V DES. The treatment plan now is for rotablation and DES for complex calcified ostial and distal RCA lesions.